Colin Keating
Colin Keating is a highly skilled executive leader with over 25 years of experience leading ASX listed and privately held businesses.
Experienced in delivering products and services through SaaS and traditional technology platforms in B2B and B2C environments.
Focuses on people and culture, with a track record of establishing high performing teams and nurturing cultures that drive growth and continuous improvement.
Known for leveraging cultures that encourage honesty, collaboration, trust, and recognition within teams.
Demonstrates an ability to identify, strategize, and execute commercial opportunities, with expertise in strategic initiatives related to people, growth, M&A, change management, and customer experience.
Has domestic and global leadership experience, having worked in London and Hong Kong, across diverse industries, from blue chips to start-up operations.
Holds a Master of Business Administration from the Australian Institute Of Business.
Currently serving as the Chief Executive Officer at MindBio Therapeutics.
Previously founded CTC Bloodstock and served as Director at Tayan Chalier Consulting.